Pilot Study of Nivolumab w/Ipilimumab or Relatlimab in Surgically Resectable Melanoma Brain Metastases
Clinical trial NCT05704933 · COMPLETED
Trial details
- NCT number
- NCT05704933
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-06
- Primary completion
- 2024-06-07
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.